CanFite Shares Quiet Following US National Institutes Of Health ClinicalTrials.gov Listing For Co.'s 'Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis'